Cell Therapy - Global Strategic Business Report 2026-2032 | Lower Costs and Broadening Cell Therapy Applications Unlock Personalized Medicine Opportunities

Dublin, Nov. 17, 2026 (GLOBE NEWSWIRE) -- "Cell Therapy - Global Strategic Business Report 2026" has been added to ResearchAndMarkets.com's offering.

The global cell therapy market was valued at US$8.7 billion in 2025 and is projected to reach US$23.6 billion by 2032, expanding at a compound annual growth rate (CAGR) of 15.4%. Market growth is being supported by rising demand for personalized medicine, increasing prevalence of chronic and complex diseases, advances in gene editing and biomanufacturing, and continued investment in regenerative medicine and oncology.

Global Cell Therapy Market Trends and Growth Drivers

Cell therapy is transforming treatment strategies across oncology, autoimmune disorders, genetic diseases, and degenerative conditions. CAR-T cell therapies have demonstrated significant clinical value in selected blood cancers, particularly among patients who have not responded to chemotherapy, radiation, or other established treatments. Research is now expanding into solid tumors, autoimmune diseases, and additional indications.

Regenerative medicine represents another major area of opportunity. Stem cell therapies are being investigated for heart failure, diabetes, spinal cord injuries, and neurodegenerative disorders. These programs are intended to restore tissue function and address cellular damage, supporting the broader transition toward targeted and individualized treatment.

Technological innovation is accelerating cell therapy development and commercialization. CRISPR-Cas9 and other gene-editing platforms are enabling more precise cellular modifications, while advances in bioprocessing, automation, and quality control are improving manufacturing consistency and scalability. Enhanced cryopreservation and logistics capabilities are also supporting the storage and global distribution of therapeutic cells.

Artificial intelligence and machine learning are increasingly being applied to process optimization, patient selection, response prediction, and clinical development. Together, these technologies are helping developers improve treatment performance, manage production complexity, and broaden the potential applications of cell-based therapies.

Market Outlook by Therapy, Application, and Region

  • Therapy segments: Allogeneic and autologous cell therapies.
  • Application segments: Research and clinical applications.
  • Geographic coverage: United States, Canada, Japan, China, Europe, Asia-Pacific, and the Rest of the World.

The allogeneic segment is forecast to reach US$13.8 billion by 2032, growing at a CAGR of 14.3%. The autologous segment is projected to record a faster CAGR of 17.1% over the analysis period.

Regionally, the United States cell therapy market was valued at US$2.5 billion in 2025. China is expected to expand at a CAGR of 14.8% and reach US$4.1 billion by 2032. The report also examines market trends and competitive developments across Japan, Canada, Germany, the wider European market, and Asia-Pacific.

Key Factors Supporting Cell Therapy Market Growth

  • Increasing incidence of cancer, autoimmune disorders, and degenerative diseases.
  • Clinical progress and commercial success of CAR-T cell therapies.
  • Growing investment in regenerative medicine and personalized treatment platforms.
  • Advances in gene editing, automated bioprocessing, cryopreservation, and cell manufacturing.
  • Regulatory pathways designed to accelerate qualifying breakthrough therapies.
  • Expansion of research into solid tumors, rare genetic disorders, and chronic conditions.

Report Scope and Strategic Value

The cell therapy market report provides independent analysis of annual sales and forecasts from 2025 through 2032. It evaluates market size, segment growth, regional opportunities, competitive conditions, technology trends, and the factors influencing adoption. The analysis is designed to help organizations identify revenue opportunities, assess market risks, benchmark competitors, and support strategic planning.

Key questions addressed include how the global cell therapy market will evolve through 2032, which segments are expected to grow most rapidly, how regional market shares may change, and which companies are positioned to influence future competition.

Companies featured include Anterogen Co., Ltd.; Cells for Cells S.A. (C4C); GSK PLC; JCR Pharmaceuticals Co., Ltd.; Kolon TissueGene, Inc.; Medipost Co., Ltd.; Novartis AG; NuVasive, Inc.; Pharmicell Co., Ltd.; and Vericel Corporation.

Domain Expert Insights

The analysis incorporates perspectives from domain experts across industry, enterprise, and academia, adding strategic context beyond conventional secondary research. The report tracks early market signals emerging from expert discussions, corporate activity, conference sessions, keynote presentations, panel discussions, company disclosures, annual reports, institutional publications, and other validated sources.

These insights Connect Group emerging developments with long-term market direction, highlighting the technologies, companies, regulatory changes, and commercial priorities most likely to influence the global cell therapy industry. Competitive analysis extends beyond a single global market share estimate by examining regional structures where market dynamics differ materially. The report also includes in-depth company intelligence and complimentary updates for one year, enabling readers to remain informed about important cell therapy market developments.

Key Attributes

Report Attribute Details
No. of Pages 312
Forecast Period 2025-2032
Estimated Market Value (USD) in 2025 $8.7 Billion
Forecasted Market Value (USD) by 2032 $23.6 Billion
Compound Annual Growth Rate 15.4%
Regions Covered Global


For more information about this report visit https://www.researchandmarkets.com/r/o6otej

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: 
CONTACT: ResearchAndMarkets.com 
         Laura Wood, Senior  Press Manager 
         press@researchandmarkets.com
         For E.S.T Office Hours Call 1-917-300-0470 
         For U.S./ CAN Toll Free Call 1-800-526-8630 
         For GMT Office Hours Call +353-1-416-8900